- Home
- CCM vs BCTX Comparison
CCM vs BCTX Comparison
Compare CCM & BCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCM
- BCTX
- Stock Information
- Founded
- CCM 1997
- BCTX 2014
- Country
- CCM China
- BCTX Canada
- Employees
- CCM N/A
- BCTX N/A
- Industry
- CCM Medical/Nursing Services
- BCTX Biotechnology: Pharmaceutical Preparations
- Sector
- CCM Health Care
- BCTX Health Care
- Exchange
- CCM Nasdaq
- BCTX Nasdaq
- Market Cap
- CCM 25.6M
- BCTX 21.8M
- IPO Year
- CCM 2009
- BCTX N/A
- Fundamental
- Price
- CCM $5.70
- BCTX $11.85
- Analyst Decision
- CCM
- BCTX Strong Buy
- Analyst Count
- CCM 0
- BCTX 1
- Target Price
- CCM N/A
- BCTX $40.00
- AVG Volume (30 Days)
- CCM 26.0K
- BCTX 78.8K
- Earning Date
- CCM 09-26-2025
- BCTX 10-27-2025
- Dividend Yield
- CCM N/A
- BCTX N/A
- EPS Growth
- CCM N/A
- BCTX N/A
- EPS
- CCM N/A
- BCTX N/A
- Revenue
- CCM $51,056,841.00
- BCTX N/A
- Revenue This Year
- CCM N/A
- BCTX N/A
- Revenue Next Year
- CCM N/A
- BCTX $380.95
- P/E Ratio
- CCM N/A
- BCTX N/A
- Revenue Growth
- CCM N/A
- BCTX N/A
- 52 Week Low
- CCM $3.80
- BCTX $6.00
- 52 Week High
- CCM $10.77
- BCTX $190.50
- Technical
- Relative Strength Index (RSI)
- CCM 47.73
- BCTX 62.04
- Support Level
- CCM $5.62
- BCTX $10.76
- Resistance Level
- CCM $6.96
- BCTX $12.76
- Average True Range (ATR)
- CCM 0.49
- BCTX 0.77
- MACD
- CCM 0.00
- BCTX -0.30
- Stochastic Oscillator
- CCM 22.25
- BCTX 39.25
About CCM Concord Medical Services Holdings Limited
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company is involved in the leasing of radiotherapy and diagnostic imaging equipment, provision of management services to hospitals, medicine sales, and provision of premium cancer and proton treatment services. The company has two operating segments, including network and hospital. Its network includes radiotherapy centers, diagnostic imaging centers, and centers providing other treatment and diagnostic services.
About BCTX BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp is a clinical-stage immuno-oncology company. The group is developing an entirely new class of targeted immunotherapies to transform cancer care. Its product candidate Bria-IMT, is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer (MBC is breast cancer that has spread to other tissues). Bria-IMT is a targeted cell-based immunotherapy. The company is engaged in developing a Bria-OTS platform of personalized off-the-shelf cell-based immunotherapies. It is being evaluated in a Phase 1/2 clinical study and the treatment is initially focused on patients with breast cancer with an extension to prostate cancer, and other cancers.